Search

The objective of the study was to investigate the post-surgical stability of clockwise rotation of the maxillary occlusal plane (MXOP) after Le Fort I osteotomy for posterior impaction and advancement, in skeletal Class III patients who had undergone two-jaw orthognathic surgery (2J-OGS).The sample set consisted of 46 patients (18 males and 28 females). Using lateral cephalograms taken at the initial evaluation (T0), before 2J-OGS (T1), after 2J-OGS (T2) and at debonding (T3), the amount of MXOP change (criterion: 2° in ΔMXOP [between T2 and T3]) was used to assign patients to Group 1 (G1, high relapse, -3.09°) or Group 2 (G2, low relapse, -0.99°). Findings were statistically compared between the groups.Compared with G2, G1 exhibited more severe skeletal Class III relationships and a flatter MXOP at T0, a greater increase in ΔANB, and more clockwise rotation of ΔMXOP and ΔFMA between T1 and T2. G1 also showed a greater decrease in ΔANB, higher counterclockwise rotation of ΔMXOP and upward movement of U1 between T2 and T3. Regression analysis yielded the following equation: MXOP (ΔT2-T3) = -0.37 X MXOP (ΔT1-T2) -0.43.The higher the clockwise rotation of the MXOP during 2J-OGS in skeletal Class III patients, the greater the subsequent relapse (counterclockwise rotation) of the MXOP.

Introduction: To investigate the post-surgical stability of clockwise rotation of the maxillary occlusal plane (MXOP) after Le Fort I osteotomy for posterior impaction and advancement in skeletal Class III patients who had undergone two-jaw orthognathic surgery (2J-OGS).Materials and methods: Sample set consisted of 46 patients [18 males and 28 females]. Using lateral cephalograms taken at the initial (T0), before 2J-OGS (T1), after (T2), and at debonding (T3), The amount of MXOP change (criterion: 2° in ΔMXOP between T2-T3) was used to assign patients to Group1[G1, high relapse, 3.09°] or Group2 [G2, low relapse, -0.99°]. Statistical analyses were then performed.Results: Compared to G2, G1 exhibited more severe skeletal Class III relationships and a flatter MXOP at T0, a greater increase in ΔANB, and more clockwise rotation of ΔMXOP and ΔFMA during T1-T2, as well as a greater decrease in ΔANB, higher counterclockwise rotation of ΔMXOP, and upward movement of U1 during T2-T3. Regression analysis resulted in formulation of the following equation: MXOP(ΔT2-T3) = -0.37 X MXOP(ΔT1-T2) -0.43. Conclusions: The higher the clockwise rotation of the MXOP during 2J-OGS in skeletal Class III patients, the greater the relapse (counterclockwise rotation) in the MXOP.

The genotypic shift of hepatitis A virus (HAV) and its correlation with clinical course has not been evaluated in acute hepatitis A (AHA).From June 2007 to May 2009, we prospectively enrolled 546 AHA patients. We performed a nested reverse transcriptase polymerase chain reaction (RT-PCR) using the serum samples in addition to phylogenetic analysis, then we compared patient clinical features.Among 351 successfully genotyped patients, we found genotype IIIA in 178 patients (51%) and IA in 173 patients (49%). The sequences of genotype IA are identical to previously reported Korean genotype IA, and the new IIIA genotype is closely related to NOR24/Norway. We retrospectively analyzed 41 AHA samples collected from 2000 to 2006 and found that all of them were genotype IA. Patients with genotype IIIA showed significantly higher levels of aspartate aminotransferase, higher levels of alanine aminotransferase, and lower platelet counts than patients with genotype IA when comparing baseline laboratory data or peak/lowest laboratory data during the disease course. However, there were no differences in duration of hospital stay, incidence of cholestatic hepatitis, acute kidney injury, and acute liver failure, or mortality between them.A genotypic shift of the HAV was identified in Korean AHA subjects, and genotype IIIA HAV has become endemic. Although there were significant differences in the biochemical responses of AHA between genotype IA and genotype IIIA patients, we did not detect any differences in clinical outcomes such as complications or mortality.